Compare DAICW & BRKRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAICW | BRKRP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2025 | 2000 |
| Metric | DAICW | BRKRP |
|---|---|---|
| Price | $0.01 | $422.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 83.3K | 2.6K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,804,369.00 | ★ $1,895,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3261.71 | N/A |
| 52 Week Low | $0.00 | $256.35 |
| 52 Week High | $0.19 | $474.99 |
| Indicator | DAICW | BRKRP |
|---|---|---|
| Relative Strength Index (RSI) | 64.08 | 47.63 |
| Support Level | $0.01 | $401.31 |
| Resistance Level | $0.02 | $463.07 |
| Average True Range (ATR) | 0.00 | 6.74 |
| MACD | 0.00 | 0.62 |
| Stochastic Oscillator | 64.71 | 63.88 |
CID Holdco Inc helps businesses digitally transform their operations using IoT and AI technology. Its main focus includes areas such as Industrial IoT, Indoor & Outdoor tracking with seamless transitions, Passive RFID (including Bluetooth and 5G), Collision Avoidance, real-time locating system, Dolly Management, and related supported software applications. The company is the developer of an asset tracking platform intended to push the limits of real-time precision-based location technology. Through its technological solutions, the Company serves multiple industries including Aviation, Construction, Delivery, Military, Mining, Retail, Sea Ports, Medical Logistics, Warehousing and Manufacturing.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.